Hydrochlorothiazide/triamterene
(Redirected from
Dyazide
)
| Combination of | |
|---|---|
| Hydrochlorothiazide | Thiazide diuretic |
| Triamterene | Potassium-sparing diuretic |
| Clinical data | |
| Trade names | Dyazide, Maxzide, others |
| Other names | co-triamterzide |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Hydrochlorothiazide/triamterene, also known as co-triamterzide, is a
low blood potassium (hypokalemia) when on only hydrochlorothiazide.[2][3] It is taken by mouth.[2][3][4]
Side effects may include nausea, trouble sleeping, dizziness,
high blood potassium.[2][3] Use in pregnancy and breastfeeding is not generally recommended.[2][3] Use in those with significant kidney problems is not recommended.[2][3] It decreases blood pressure mainly by hydrochlorothiazide while triamterene decreases the amount of potassium lost.[2][3]
The combination was approved for medical use in the United States in 1965.[5] In 2021, it was the 112th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[6][7]
References
- FDA. Retrieved 22 October 2023.
- ^ a b c d e f g h i j "Dyazide- hydrochlorothiazide and triamterene capsule". DailyMed. 31 October 2017. Retrieved 20 August 2020.
- ^ a b c d e f g h i j "Maxzide-25- maxzide tablet Maxzide tablet". DailyMed. 20 July 2018. Retrieved 20 August 2020.
- ^ ISBN 9780857113382.
- ^ "Dyazide: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 20 August 2020.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Hydrochlorothiazide; Triamterene - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
